Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / July / Sport: The Precision Medicine Vanguard
Omics Omics Metabolomics & Lipidomics Innovation

Sport: The Precision Medicine Vanguard

Armed with ever-more practical and powerful sampling devices, omics workflows, and wearable tech, could elite athletes pioneer a more precise approach to sport – and health? 

By James Strachan 07/13/2026 20 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Clinical Report: Sport: The Precision Medicine Vanguard

Background

The intersection of sports and precision medicine is increasingly relevant as athletes seek to optimize performance while managing health conditions. The case of Britton Needham illustrates how disciplined monitoring of blood glucose can enable athletes with type-1 diabetes to compete at elite levels.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • Britton Needham successfully managed type-1 diabetes through meticulous dietary and training adjustments.
  • Researchers have identified metabolomic signatures that distinguish between varying levels of athletic performance.
  • Top-performing cyclists maintained fat-burning capacity during races.
  • Ultra-endurance athletes exhibit significant inflammatory responses and red blood cell turnover during extreme exertion.
  • Technological advancements allow for real-time monitoring of physiological data.

Clinical Implications

The findings suggest that athletes with chronic conditions can leverage precision medicine strategies to enhance their performance. Coaches and healthcare providers may consider integrating continuous monitoring technologies to optimize training and recovery protocols.

Conclusion

The integration of precision medicine in sports represents a significant advancement in how athletes manage health and performance, particularly for those with chronic conditions like type-1 diabetes.

Related Resources & Content

  1. The Analytical Scientist, 2026 -- From Peak Performance to Precision Healthcare
  2. The ASCO Post, 2018 -- Precision Medicine: Hope or Hype?
  3. BMJ Paediatrics Open, 2023 -- Precision for all children: embedding equity into precision medicine for children
  4. American Diabetes Association -- The American Diabetes Association Releases “Standards of Care in Diabetes—2026”
  5. EASD and ISPAD -- The use of automated insulin delivery around physical activity and exercise in type 1 diabetes
  6. The ASCO Post — Big Data and the Promise of Precision Medicine in Cancer
  7. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  8. The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.